Cargando…

Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer

A 66-year-old male patient who had received chemoradiotherapy (CRT) for laryngeal cancer 2 years ago visited a local doctor complaining of dyspnoea and wheezing. CT scan showed narrowing of the trachea caused by a tumour. We intubated the trachea over the tumour using a bronchoscope. A week later, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Saikawa, Hirotaka, Uesugi, Noriyuki, Sugai, Tamotsu, Maemondo, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604805/
https://www.ncbi.nlm.nih.gov/pubmed/33127699
http://dx.doi.org/10.1136/bcr-2020-236819
_version_ 1783604198437289984
author Saikawa, Hirotaka
Uesugi, Noriyuki
Sugai, Tamotsu
Maemondo, Makoto
author_facet Saikawa, Hirotaka
Uesugi, Noriyuki
Sugai, Tamotsu
Maemondo, Makoto
author_sort Saikawa, Hirotaka
collection PubMed
description A 66-year-old male patient who had received chemoradiotherapy (CRT) for laryngeal cancer 2 years ago visited a local doctor complaining of dyspnoea and wheezing. CT scan showed narrowing of the trachea caused by a tumour. We intubated the trachea over the tumour using a bronchoscope. A week later, the truncated tracheal tumour obstructed the tracheal tube, compromising the patient’s breathing. We removed the obstructed tube and inserted a new one. We submitted the tissue from the tube to a pathologist. Histopathological diagnosis was pleomorphic carcinoma, a subtype of sarcomatoid carcinoma. The mechanism of epithelial–mesenchymal transition (EMT) occurring after CRT was detected in the tumour. Because he had undergone CRT for laryngeal cancer, surgery was not indicated, and we started radiation therapy. Sarcomatoid carcinomas including pleomorphic carcinoma of the trachea are extremely rare, with few reported cases, and EMT is associated with this histological type and CRT.
format Online
Article
Text
id pubmed-7604805
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-76048052020-11-12 Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer Saikawa, Hirotaka Uesugi, Noriyuki Sugai, Tamotsu Maemondo, Makoto BMJ Case Rep Rare Disease A 66-year-old male patient who had received chemoradiotherapy (CRT) for laryngeal cancer 2 years ago visited a local doctor complaining of dyspnoea and wheezing. CT scan showed narrowing of the trachea caused by a tumour. We intubated the trachea over the tumour using a bronchoscope. A week later, the truncated tracheal tumour obstructed the tracheal tube, compromising the patient’s breathing. We removed the obstructed tube and inserted a new one. We submitted the tissue from the tube to a pathologist. Histopathological diagnosis was pleomorphic carcinoma, a subtype of sarcomatoid carcinoma. The mechanism of epithelial–mesenchymal transition (EMT) occurring after CRT was detected in the tumour. Because he had undergone CRT for laryngeal cancer, surgery was not indicated, and we started radiation therapy. Sarcomatoid carcinomas including pleomorphic carcinoma of the trachea are extremely rare, with few reported cases, and EMT is associated with this histological type and CRT. BMJ Publishing Group 2020-10-30 /pmc/articles/PMC7604805/ /pubmed/33127699 http://dx.doi.org/10.1136/bcr-2020-236819 Text en © BMJ Publishing Group Limited 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Rare Disease
Saikawa, Hirotaka
Uesugi, Noriyuki
Sugai, Tamotsu
Maemondo, Makoto
Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
title Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
title_full Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
title_fullStr Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
title_full_unstemmed Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
title_short Pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
title_sort pleomorphic carcinoma of the trachea after chemoradiotherapy for laryngeal cancer
topic Rare Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604805/
https://www.ncbi.nlm.nih.gov/pubmed/33127699
http://dx.doi.org/10.1136/bcr-2020-236819
work_keys_str_mv AT saikawahirotaka pleomorphiccarcinomaofthetracheaafterchemoradiotherapyforlaryngealcancer
AT uesuginoriyuki pleomorphiccarcinomaofthetracheaafterchemoradiotherapyforlaryngealcancer
AT sugaitamotsu pleomorphiccarcinomaofthetracheaafterchemoradiotherapyforlaryngealcancer
AT maemondomakoto pleomorphiccarcinomaofthetracheaafterchemoradiotherapyforlaryngealcancer